Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?

about

Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve Edoxaban: pharmacological principles, preclinical and early-phase clinical testing.Relevance of immobility and importance of risk assessment management for medically ill patients.

P2860

Q34195910-42BA8C54-20E7-4AAA-9287-BDA003B4D076 Q37907319-81838C89-A2C8-4433-8DD8-6651702E4409 Q38028928-DAEFC2E6-057D-4311-95CD-2D993E62FF96

P2860

Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?

Item

http://www.wikidata.org/entity/Q36632271

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Extended duration of thrombopr ...... patients: optimizing therapy?

@ast

Extended duration of thrombopr ...... patients: optimizing therapy?

@en

type

Item

label

Extended duration of thrombopr ...... patients: optimizing therapy?

@ast

Extended duration of thrombopr ...... patients: optimizing therapy?

@en

prefLabel

Extended duration of thrombopr ...... patients: optimizing therapy?

@ast

Extended duration of thrombopr ...... patients: optimizing therapy?

@en

P1476

Extended duration of thrombopr ...... patients: optimizing therapy?

@en

P2093

Turpie AG

http://www.w3.org/2001/XMLSchema#string

P2860

Venous thrombosis in cancer patients: insights from the FRONTLINE survey

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke.

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.

The prevalence of risk factors for venous thromboembolism among hospital patients.

Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.

P304

5-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7836.2006.02268.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6737497

http://www.w3.org/2001/XMLSchema#string

P698

17059417

http://www.w3.org/2001/XMLSchema#string

Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?

about

P2860

P2860

Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698